Home › Companies › Health Care › XENE
Is Xenon Pharmaceuticals Inc. a Buffett stock?
Get the full Buffett-style verdict on XENE: intrinsic value, margin of safety, moat and the complete checklist. Free, in about 10 seconds.
Run the Buffett-style test on XENE10 years at a glance
Loading Xenon Pharmaceuticals Inc.’s numbers from its SEC filings…
XENE earnings: beat or miss?
Loading the earnings history…
How Buffett would look at Xenon Pharmaceuticals Inc.
Health care can be a wonderful business, but the numbers can swing with patents and trial results. Buffett-style questions:
- Does the company depend on a few products? A patent cliff can erase a big share of profit in a few years.
- Steady earnings over a full decade, not only in the years after a hit drug or device launched.
- Sensible capital allocation. Big acquisitions paid for with debt are a common way health care companies destroy value.
- Return on equity without heavy debt. High returns built on borrowing are weaker than they look.
Quantifylt runs these checks on XENE automatically from its annual reports, then estimates what the business is worth and compares that with today’s price.
Questions about XENE
Is Xenon Pharmaceuticals Inc. a Buffett stock?
It depends on whether Xenon Pharmaceuticals Inc. has a durable competitive advantage, consistent earnings, high returns on equity without heavy debt, and trades below its intrinsic value. The quick checks on this page use 10 years of SEC filings; the free full analysis on Quantifylt adds intrinsic value, margin of safety, moat and red flags.
When does Xenon Pharmaceuticals Inc. report earnings?
The next expected report date for XENE is shown in the earnings section above, with analyst estimates and whether the company beat or missed in each of the last four quarters. Companies usually report three to six weeks after each quarter ends.
Can I hold XENE in a TFSA or RRSP?
Yes. Xenon Pharmaceuticals Inc. trades on the Toronto Stock Exchange, so it can be held in a TFSA, RRSP or FHSA, and its dividends aren't subject to foreign withholding tax. In a regular taxable account, its Canadian dividends may qualify for the dividend tax credit. This is general information, not tax advice.
Should I buy XENE stock?
Quantifylt doesn't tell anyone to buy or sell. It shows how Xenon Pharmaceuticals Inc. measures up against Warren Buffett's published principles so you can make your own decision. Consider your goals and, if needed, speak with a registered adviser.